Company Data

Spyre Therapeutics Inc.

Ticker
SYRE
Current Price
$15.28 -1.74%
Market Cap
$922.2M
Price Target
Refer to Report
Volume
380.8K
52wk Range
$10.91 - $40.26
Advanced Market Data

Overview

Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company’s lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy